Innovative Sitagliptin Solutions for Type 2 Diabetes: Explore the SITANOW Range

Apr 18, 2025

Apr 18, 2025

Effective diabetes management continues to evolve with advancements in pharmaceuticals. Among the leading solutions is the SITANOW series from Intra Life Pharma, designed to support improved glycemic control in adults with Type 2 Diabetes Mellitus. With clinically approved compositions and trusted manufacturing standards, these medicines serve as valuable options for patients and healthcare providers.

Why Sitagliptin-Based Therapy?

Sitagliptin is a DPP-IV inhibitor that enhances the body’s ability to lower elevated blood sugar levels. It works by increasing the concentration of incretin hormones (GLP-1 and GIP), which stimulate insulin release and suppress glucagon production. This dual action supports sustained glycemic control, reduces hypoglycemic episodes, and helps manage body weight effectively.

Product Overview

SITANOW-100
This tablet contains SITANOW-100 mg, offering once-daily dosing to support glycemic control. It’s ideal as an add-on therapy to insulin-metformin regimens. Compared to glimepiride, SITANOW-100 has shown superior outcomes in managing BMI, body weight, and insulin dependency among Asian Indian patients. It is one of the most recommended choices by physicians and a top product by a Sitagliptin tablets supplier like Intra Life Pharma.

SITANOW-50
A lower-dose variant, SITANOW-50, provides Sitagliptin 50mg per tablet. This formulation suits patients who require a gradual dosage approach or combination therapy. Intra Life Pharma ensures this product adheres to global standards, positioning it as a reliable Sitagliptin manufacturer for high-demand clinical settings.

SITANOW-M 1000
Combining Sitagliptin 50mg with Metformin 1000mg, SITANOW-M 1000 offers a comprehensive solution for patients needing stronger metabolic control. This dual-combination therapy provides significant glycemic improvements, weight regulation, and is typically prescribed for long-term treatment plans. As a trusted Sitagliptin + Metformin exporter, Intra Life Pharma has gained recognition across various international healthcare markets.

SITANOW-M 500
Formulated with Sitagliptin 50mg and Metformin 500mg, SITANOW-M 500 delivers potent anti-diabetic support with a moderate dosage. It’s well-tolerated, aids in body weight regulation, and helps maintain optimal blood sugar levels over time. This product is a valuable addition from a leading Sitagliptin + Metformin dealer committed to quality and innovation.

Clinical Benefits of the SITANOW Range

Improved Glycemic Control: All four products are designed to maintain balanced sugar levels through DPP-IV inhibition and insulin modulation.
Weight & BMI Support: Sitagliptin therapies have been shown to reduce BMI and support weight management in Type 2 Diabetes patients.
FDA-Approved Actives: Each formulation includes Sitagliptin, an FDA-approved DPP-IV inhibitor, known for safety and efficacy.
Flexible Dosing Options: From 50mg to 1000mg combinations, SITANOW tablets suit a range of patient needs.

Trusted by Professionals, Backed by Science

At Intra Life Pharma, we prioritise the latest clinical research and stringent manufacturing protocols to deliver high-quality diabetes care solutions. As a reputed Sitagliptin manufacturer and exporter, we support both domestic and global markets with accessible, effective treatments.

Looking for advanced formulations like Empasug -M 500/12.5? Explore our full product portfolio on the Contact Us page or get in touch today.